Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTAW) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $38.2 million.

  • Strata Critical Medical's Other Operating Expenses rose 3220.87% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.5 million, marking a year-over-year increase of 4797.51%. This contributed to the annual value of $197.7 million for FY2024, which is 218.51% up from last year.
  • Strata Critical Medical's Other Operating Expenses amounted to $38.2 million in Q3 2025, which was up 3220.87% from $54.7 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Other Operating Expenses high stood at $110.8 million for Q4 2024, and its period low was $8.4 million during Q1 2021.
  • For the 5-year period, Strata Critical Medical's Other Operating Expenses averaged around $39.8 million, with its median value being $38.3 million (2022).
  • As far as peak fluctuations go, Strata Critical Medical's Other Operating Expenses soared by 567688.97% in 2021, and later crashed by 5069.43% in 2024.
  • Strata Critical Medical's Other Operating Expenses (Quarter) stood at $22.1 million in 2021, then soared by 61.47% to $35.6 million in 2022, then grew by 14.79% to $40.9 million in 2023, then surged by 171.14% to $110.8 million in 2024, then tumbled by 65.57% to $38.2 million in 2025.
  • Its last three reported values are $38.2 million in Q3 2025, $54.7 million for Q2 2025, and $43.8 million during Q1 2025.